Surgery Today

, Volume 42, Issue 3, pp 238–244 | Cite as

Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer

  • Noriyoshi Sawabata
  • Hajime Maeda
  • Akihide Matsumura
  • Mitsunori Ohta
  • Meinoshin Okumura
  • The Thoracic Surgery Study Group of Osaka University
Original Article



A pulmonary wedge resection is useful for the treatment of peripheral non-small cell lung cancer (NSCLC). The margin/tumor size ratio (M/T) is a predictor of positive margin cytology findings in these procedures, although the long-term clinical implications remain unclear. This relationship was investigated in this study.


Thirty-seven cases with a high surgical risk without additional pulmonary resection were selected from those accrued in a multicenter prospective study of optimal margin distance for pulmonary excision of peripheral NSCLC and followed for more than 5 years (range 5.3–14 years).


Both the M/T and margin cytology findings were indicators of cancer recurrence and survival. All seven cases of surgical margin recurrence had a cytology-positive surgical margin. The 5-year survival rate was 54.2% (n = 24) for M/T < 1 and 84.6% for M/T ≥ 1 (n = 13, P = 0.05), while it was 38.5% for positive margin (n = 13) and 79.2% for negative margin (n = 24) cases (P = 0.001). In addition, the margin cytology findings were an independent prognostic factor.


A pulmonary wedge resection for peripheral NSCLC should result in a negative malignant margin, which might be obtained from a sufficient tumor margin ratio of M/T ≥ 1.


Non-small cell lung cancer Pulmonary excision Margin cytology Margin/tumor ratio Prognosis 


  1. 1.
    Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW, American College of Chest Physicians. Treatment of non-small cell lung cancer-Stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132S:234s–42s.Google Scholar
  2. 2.
    Fukui T, Mitsudomi T. Small peripheral lung adenocarcinoma: clinicopathological features and surgical treatment. Surg Today. 2010;40:191–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg. 2006;132:769–75.PubMedCrossRefGoogle Scholar
  4. 4.
    Sawabata N, Karube Y, Umezu H, Tamura M, Seki N, Ishihama H, et al. Cytologically malignant margin without continuous pulmonary tumor lesion: cases of wedge resection segmentectomy and lobectomy. Interact Cardiovasc Thorac Surg. 2008;7:1044–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Sawabata N, Matsumura A, Ohota M, Maeda H, Hirano H, Nakagawa K, Thoracic Surgery Study Group of Osaka University, et al. Cytologically malignant margins of wedge resected stage I non-small cell lung cancer. Ann Thorac Surg. 2003;74:1953–7.CrossRefGoogle Scholar
  6. 6.
    Higashiyama M, Kodama K, Takami K, Higaki N, Nakayama T, Yokouchi H. Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer. J Thorac Cardiovasc Surg. 2003;125:101–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Sawabata N, Ohta M, Matsumura A, Nakagawa K, Hirano H, Maeda H, et al. Optimal distance of malignant negative margin in excision of non-small cell lung cancer: a multicenter prospective study. Ann Thorac Surg. 2004;77:415–20.PubMedCrossRefGoogle Scholar
  8. 8.
    National Institutes of Health. National Cancer Institute. CALGB-140503. Phase III randomized study of lobectomy versus sublobar resection in patients with small peripheral stage IA non-small cell lung cancer. Accessed 20 June 2010.
  9. 9.
    Lewis RJ, Caccavale RJ, Sisler GE, Mackenzie JW. Video-assisted thoracic surgical resection of malignant lung tumors. J Thorac Cardiovasc Surg. 1992;104:1679–85.PubMedGoogle Scholar
  10. 10.
    Sawabata N, Mori T, Iuchi K, Maeda H, Ohta M, Kuwahara O. Cytologic examination of surgical margin of excised malignant pulmonary tumor: methods and early results. J Thorac Cardiovasc Surg. 1999;117:618–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Masasyesva BG, Tong BC, Brock MV, Pilkington T, Goldenberg D, Sidransky D, et al. Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer. Int J Cancer. 2005;113:1022–5.PubMedCrossRefGoogle Scholar
  12. 12.
    El-Sherif A, Gooding WE, Santos R, Pettiford B, Ferson PF, Fernando HC, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg. 2006;82:408–15.PubMedCrossRefGoogle Scholar
  13. 13.
    Landreneau RJ, Sugarbaker DJ, Mack MJ, Hazelrigg SR, Luketich JD, Fetterman L, et al. Wedge resection versus lobectomy for stage I (T1N0M0) non-small cell lung cancer. J Thorac Cardiovasc Surg. 1997;113:698–700.CrossRefGoogle Scholar
  14. 14.
    Errett LE, Wilson J, Chiu RC, Munro DD. Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor risk patients. J Thorac Cardiovasc Surg. 1985;90:656–61.PubMedGoogle Scholar
  15. 15.
    Miller JI, Hatcher CR Jr. Limited resection of bronchogenic carcinoma in the patients with marked impairment of pulmonary function. Ann Thorac Surg. 1987;44:340–3.PubMedCrossRefGoogle Scholar
  16. 16.
    Jensik RJ, Feber LP, Milloy FJ, Monson DO. Segmental resection for lung cancer; a fifteen-year experience. J Thorac Cardiovasc Surg. 1973;66:563–72.PubMedGoogle Scholar
  17. 17.
    Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1996;62:1249–50.CrossRefGoogle Scholar
  18. 18.
    Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma Five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg. 1994;107:1087–93.PubMedGoogle Scholar
  19. 19.
    Kodama K, Doi O, Higashiyama M, Yokouchi H. Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg. 1997;114:347–53.PubMedCrossRefGoogle Scholar
  20. 20.
    Yoshikawa K, Tsubota N, Kodama K, Ayabe H, Taki T, Mori T. Prospective study of extended segmentectomy for small lung tumors: the final report. Ann Thorac Surg. 2002;73:1055–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Keenan RJ, Landreneau RJ, Maley RH Jr, Singh D, Macherey R, Bartley S, et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg. 2004;78:228–33.PubMedCrossRefGoogle Scholar
  22. 22.
    Schuchert MJ, Pettiford BL, Keeley S, D’Amato TA, Kilic A, Close J, et al. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg. 2007;84:926–32.PubMedCrossRefGoogle Scholar
  23. 23.
    Fernando HC, Santos RS, Benfield JR, Grannis FW, Keenan RJ, Luketich JD, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;129:261–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2011

Authors and Affiliations

  • Noriyoshi Sawabata
    • 1
  • Hajime Maeda
    • 1
  • Akihide Matsumura
    • 1
  • Mitsunori Ohta
    • 1
  • Meinoshin Okumura
    • 1
  • The Thoracic Surgery Study Group of Osaka University
  1. 1.Department of General Thoracic SurgeryOsaka University Graduate School of MedicineSuitaJapan

Personalised recommendations